Calamos Advisors
CELG

Calamos Advisors’s Celgene Corp CELG Stock Holding History

Calamos Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-275,000
Closed -$24.5M – 653
2018
Q1 		$24.5M Buy
+275,000
New +$26.4M 0.16% 180
2014
Q3 		– Sell
-940
Closed -$632K – 697
2014
Q2 		$632K Buy
+940
New +$71.5K ﹤0.01% 582
2014
Q1 		– Sell
-7,130
Closed -$16.2M – 695
2013
Q4 		$16.2M Sell
7,130
-600
-8% -$47.5K 0.1% 196
2013
Q3 		$13.3M Buy
+7,730
New +$542K 0.08% 222

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Calamos Advisors's CELG Position: Q4 2019 in Review

Calamos Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 255,799 shares — an estimated $25.4M sold.

Calamos Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $156M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Calamos Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Calamos Advisors sold 255,799 Celgene Corp shares in Q4 2019, an estimated $25.4M.
  • Calamos Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Calamos Advisors's Celgene Corp position peaked at $156M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Calamos Advisors's 13F filing for Q4 2019, filed 15 Jan 2020.